Translational research into the mechanisms and consequences of cardiac ischaemia with a view to developing and evaluating novel and personalised treatments for ischaemic heart disease. The group employs diverse research methodologies to achieve these aims, from exploration of the pathophysiological basis of disease states by detailed characterisation of patients during diagnostic and therapeutic procedures through designing and conducting mutlicentre randomised clinical trials to applying machine learning and Artificial Intelligence techniques to data extracted from routine health records.

The group has established multi-disciplinary collaborations within King's (cross-cutting with imaging sciences, biomedical engineering, cardiac electrophysiology, clinical pharmacology and basic sciences) and with several national and international academic cardiovascular centres.

Their research is funded by peer-reviewed grants from charities (including the British Heart Foundation, Medical Research Council, Heart Research UK, Guy’s & St Thomas’ Charity) and public funding (UK National Institute for Health Research and US National Institute for Health) as well as investigator-initiated commercial funding.

The group also engages in teaching and mentoring undergraduate and postgraduate teaching including cardiovascular BSc and MSc students as well as Academic Clinical Fellows.